Analyst Research

Report Title Price
Provider: Wright Reports
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Hyperion Therapeutics Inc Announces Pricing Of Follow-On Offering

Friday, 8 Mar 2013 09:15am EST 

Hyperion Therapeutics Inc announced that the pricing of its follow-on offering of 2,875,000 shares of its common stock at $20.75 per share, before underwriting discounts and commissions. All of the common stock is being offered by Hyperion. In addition, the underwriters have a 30-day option to purchase up to an additional 431,250 shares of common stock from Hyperion to cover over-allotments, if any. The offering is expected to close on March 13, 2013, subject to customary closing conditions. Leerink Swann LLC and Cowen and Company, LLC are serving as joint book-running managers for the proposed offering. Needham & Company, LLC and JMP Securities LLC are acting as co-managers for the proposed offering. 

Company Quote

1.305 +5.64%
30 Oct 2014